—
Chinese AI drug researcher XtalPi expects to turn first annual profit on 193% revenue jump
Chinese AI-powered drug researcher XtalPi Holdings has announced it expects to achieve its first annual profit in 2025, projecting a net profit of at least 100 million yuan compared to a net loss of approximately 1.5 billion yuan in 2024. The Shenzhen-based company attributed the turnaround to a 193% jump in revenue. The announcement was made via a filing with the Hong Kong Stock Exchange.